So far only one oral GLP-1 has appeared on the market, in 2019
Adults with Overweight & Comorbidities: Individuals with a BMI of 27 kg/m or higher who also have at least one weight-related medical condition, such as hypertension (high blood pressure), type 2 diabetes, or dyslipidemia (high cholesterol)
Case in point: In a study of 121 subjects, researchers found that those who took 14 grams of allulose a day had a statistically significant decrease in body mass index (BMI), abdominal, and subcutaneous fat compared to those who took a placebo, though absolute losses were small (around .75% of body fat)
Evidence shows that psychosocial interventions are most effective in at-risk subgroups
BioTrust GLP-1 Elevate GLP-1 Elevate delivers a science-backed blend of functional fibers, botanicals, and minerals designed to promote natural GLP-1 levels